Published in Lancet on February 23, 2002
War, bioterrorism, and the political landscape. Lancet (2002) 1.46
Comparison and evaluation of methods for liver segmentation from CT datasets. IEEE Trans Med Imaging (2009) 3.03
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis (2002) 2.89
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35
An outbreak of Norovirus infection affecting an Austrian nursing home and a hospital. Wien Klin Wochenschr (2005) 2.18
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol (2005) 1.87
Classifying spa types in complexes improves interpretation of typing results for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 1.50
[Food borne infectious outbreaks, Austria 2005]. Wien Klin Wochenschr (2007) 1.48
The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis (2007) 1.48
Influenza-related excess mortality, Austria 2001 till 2009. Wien Klin Wochenschr (2011) 1.44
Co-infection with two Chlamydophila species in a case of fulminant myocarditis. Crit Care Med (2007) 1.43
Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol (2009) 1.43
Infection of red deer, cattle, and humans with Mycobacterium bovis subsp. caprae in western Austria. J Clin Microbiol (2002) 1.37
Rapid identification of multidrug-resistant Mycobacterium tuberculosis isolates by rpoB gene scanning using high-resolution melting curve PCR analysis. J Antimicrob Chemother (2009) 1.30
Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol (2009) 1.29
Listeria rocourtiae sp. nov. Int J Syst Evol Microbiol (2009) 1.21
Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains. Int J Antimicrob Agents (2005) 1.20
Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res Microbiol (2006) 1.19
Complement-HIV interactions during all steps of viral pathogenesis. Vaccine (2007) 1.19
Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses. Mol Immunol (2005) 1.15
Potential basis for amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother (2008) 1.11
Phagocytosis and killing of bacteria by professional phagocytes and dendritic cells. Clin Diagn Lab Immunol (2002) 1.10
Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J Immunol (2004) 1.10
Complement-opsonized HIV: the free rider on its way to infection. Mol Immunol (2005) 1.09
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol (2004) 1.08
Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk. Int J Infect Dis (2003) 1.07
Role of complement in the control of HIV dynamics and pathogenesis. Vaccine (2003) 1.06
Multiple-locus variable-number tandem repeat analysis for subtyping of Salmonella enterica subsp. enterica serovar Enteritidis. Int J Med Microbiol (2008) 1.05
HIV-infection of the central nervous system: the tightrope walk of innate immunity. Mol Immunol (2005) 1.04
Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis (2003) 1.04
Epidemiology of listeriosis in Austria. Wien Klin Wochenschr (2009) 1.04
IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells. J Immunol (2007) 1.02
Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells. J Immunol (2006) 1.01
Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway. J Immunol (2003) 1.00
Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J Virol (2002) 1.00
Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro. Antimicrob Agents Chemother (2008) 0.98
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrob Agents Chemother (2008) 0.97
Lessons learned from a Salmonella enteritidis phage type 4 outbreak in Austria, 2005. J Food Prot (2007) 0.97
Autochthonous Dirofilaria repens in Austria. Parasit Vectors (2014) 0.97
Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol (2007) 0.96
Occurrence of Vibrio cholerae serogroups other than O1 and O139 in Austria. Wien Klin Wochenschr (2007) 0.96
Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis (2008) 0.96
HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity. Mol Immunol (2004) 0.95
Mechanisms behind variation in the Clostridium difficile 16S-23S rRNA intergenic spacer region. J Med Microbiol (2010) 0.94
Gene Scanning of an Internalin B Gene Fragment Using High-Resolution Melting Curve Analysis as a Tool for Rapid Typing of Listeria monocytogenes. J Mol Diagn (2010) 0.94
One-step triplex high-resolution melting analysis for rapid identification and simultaneous subtyping of frequently isolated Salmonella serovars. Appl Environ Microbiol (2012) 0.94
Outbreak of leptospirosis among triathlon participants in Langau, Austria, 2010. Wien Klin Wochenschr (2011) 0.93
HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J Immunol (2004) 0.93
An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007. Wien Klin Wochenschr (2009) 0.92
A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum. Front Biosci (2007) 0.92
C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells. Eur J Immunol (2005) 0.92
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro. Antimicrob Agents Chemother (2006) 0.92
Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS (2005) 0.92
Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans. Expert Rev Anti Infect Ther (2008) 0.91
Diagnosis of bacteria in vitro by mass spectrometric fingerprinting:a pilot study. Curr Microbiol (2005) 0.91
An outbreak of febrile gastroenteritis associated with jellied pork contaminated with Listeria monocytogenes. Wien Klin Wochenschr (2009) 0.91
Detection of virulence-associated and regulatory protein genes in association with phage typing of human Vibrio cholerae from several geographical regions of the world. J Med Microbiol (2009) 0.90
A foodborne outbreak of Salmonella Enteritidis phage type 6 in Austria, 2008. Wien Klin Wochenschr (2009) 0.90
Preliminary validation of real-time PCR assays for the identification of Yersinia pestis. Clin Chem Lab Med (2008) 0.89
HIV and human complement: inefficient virolysis and effective adherence. Immunol Lett (2004) 0.89
Emergence of VIM-1-carbapenemase-producing Enterobacter cloacae in Tyrol, Austria. J Med Microbiol (2011) 0.89
Neuroinvasion by pathogens: a key role of the complement system. Mol Immunol (2002) 0.89
Clostridium difficile: a new zoonotic agent? Wien Klin Wochenschr (2009) 0.89
Ongoing outbreak of invasive listeriosis, Germany, 2012 to 2015. Euro Surveill (2015) 0.88
Outbreak of staphylococcal food intoxication after consumption of pasteurized milk products, June 2007, Austria. Wien Klin Wochenschr (2009) 0.88
Serine protease espP subtype alpha, but not beta or gamma, of Shiga toxin-producing Escherichia coli is associated with highly pathogenic serogroups. Int J Med Microbiol (2008) 0.88
Complement synthesis and activation in the brain of SIV-infected monkeys. J Neuroimmunol (2004) 0.87
Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia. Int J Med Microbiol (2006) 0.87
Mechanisms promoting dendritic cell-mediated transmission of HIV. Mol Immunol (2005) 0.87
Human granulocytic anaplasmosis in Austria: epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria. Int J Med Microbiol (2006) 0.87
Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157 in Austria. Wien Klin Wochenschr (2009) 0.87
Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro. Mycoses (2008) 0.86
Partial teicoplanin dependence in a vancomycin-dependent Enterococcus faecium isolated from an oncology patient 1 month after cessation of teicoplanin therapy, Austria 2007. Int J Antimicrob Agents (2007) 0.86
Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile. J Med Microbiol (2011) 0.86
Prevalence, structure and expression of urease genes in Shiga toxin-producing Escherichia coli from humans and the environment. Int J Hyg Environ Health (2006) 0.86
In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus. Antimicrob Agents Chemother (2005) 0.86
Outbreak of norovirus infection associated with contaminated flood water, Salzburg, 2005. Euro Surveill (2005) 0.86
A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity. J Immunol Methods (2004) 0.86
Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection. Antimicrob Agents Chemother (2012) 0.86
A non-foodborne norovirus outbreak among school children during a skiing holiday, Austria, 2007. Wien Klin Wochenschr (2009) 0.85
Complement and antibodies: a dangerous liaison in HIV infection? Vaccine (2008) 0.85
Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures. Eur J Immunol (2003) 0.85
Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study. J Clin Microbiol (2012) 0.85
Travel-associated rabies in Austrian man. Emerg Infect Dis (2005) 0.85
Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs. PLoS Pathog (2010) 0.84
Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. Int J Antimicrob Agents (2007) 0.84
Hospital antibiotic management in Austria--results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr (2008) 0.84
Stress survival islet 1 (SSI-1) survey in Listeria monocytogenes reveals an insert common to listeria innocua in sequence type 121 L. monocytogenes strains. Appl Environ Microbiol (2011) 0.84
High-resolution melting analysis of the single nucleotide polymorphism hot-spot region in the rpoB gene as an indicator of reduced susceptibility to rifaximin in Clostridium difficile. J Med Microbiol (2012) 0.84
Cytolethal distending toxins in Shiga toxin-producing Escherichia coli: alleles, serotype distribution and biological effects. J Med Microbiol (2006) 0.84
Routine surface disinfection in health care facilities: should we do it? Am J Infect Control (2002) 0.84
Combined cardiac and respiratory motion compensation for atrial fibrillation ablation procedures. Med Image Comput Comput Assist Interv (2011) 0.84
Chlamydophila abortus pelvic inflammatory disease. Emerg Infect Dis (2003) 0.84